These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29101624)

  • 21. Zinc-finger protein 418 overexpression protects against cardiac hypertrophy and fibrosis.
    Pan L; Sheng M; Huang Z; Zhu Z; Xu C; Teng L; He L; Gu C; Yi C; Li J
    PLoS One; 2017; 12(10):e0186635. PubMed ID: 29065170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxia-Induced Mitogenic Factor Promotes Cardiac Hypertrophy via Calcium-Dependent and Hypoxia-Inducible Factor-1α Mechanisms.
    Kumar S; Wang G; Liu W; Ding W; Dong M; Zheng N; Ye H; Liu J
    Hypertension; 2018 Aug; 72(2):331-342. PubMed ID: 29891648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maf1 ameliorates cardiac hypertrophy by inhibiting RNA polymerase III through ERK1/2.
    Sun Y; Chen C; Xue R; Wang Y; Dong B; Li J; Chen C; Jiang J; Fan W; Liang Z; Huang H; Fang R; Dai G; Yan Y; Yang T; Li X; Huang ZP; Dong Y; Liu C
    Theranostics; 2019; 9(24):7268-7281. PubMed ID: 31695767
    [No Abstract]   [Full Text] [Related]  

  • 24. GDF11 Attenuated ANG II-Induced Hypertrophic Cardiomyopathy and Expression of ANP, BNP and Beta-MHC Through Down- Regulating CCL11 in Mice.
    Zhang C; Wang Y; Ge Z; Lin J; Liu J; Yuan X; Lin Z
    Curr Mol Med; 2018; 18(10):661-671. PubMed ID: 30714521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breviscapine protects against cardiac hypertrophy through blocking PKC-alpha-dependent signaling.
    Yan L; Huang H; Tang QZ; Zhu LH; Wang L; Liu C; Bian ZY; Li H
    J Cell Biochem; 2010 Apr; 109(6):1158-71. PubMed ID: 20127712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual specific phosphatase 12 ameliorates cardiac hypertrophy in response to pressure overload.
    Li WM; Zhao YF; Zhu GF; Peng WH; Zhu MY; Yu XJ; Chen W; Xu DC; Xu YW
    Clin Sci (Lond); 2017 Jan; 131(2):141-154. PubMed ID: 27702885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KMUP-1 Attenuates Endothelin-1-Induced Cardiomyocyte Hypertrophy through Activation of Heme Oxygenase-1 and Suppression of the Akt/GSK-3β, Calcineurin/NFATc4 and RhoA/ROCK Pathways.
    Liou SF; Hsu JH; Chen YT; Chen IJ; Yeh JL
    Molecules; 2015 Jun; 20(6):10435-49. PubMed ID: 26056815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Propranolol causes a paradoxical enhancement of cardiomyocyte foetal gene response to hypertrophic stimuli.
    Patrizio M; Musumeci M; Stati T; Fasanaro P; Palazzesi S; Catalano L; Marano G
    Br J Pharmacol; 2007 Sep; 152(2):216-22. PubMed ID: 17592507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR-dependent signaling.
    Ai W; Zhang Y; Tang QZ; Yan L; Bian ZY; Liu C; Huang H; Bai X; Yin L; Li H
    J Cell Biochem; 2010 Aug; 110(5):1111-22. PubMed ID: 20564207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Syringin prevents cardiac hypertrophy induced by pressure overload through the attenuation of autophagy.
    Li F; Zhang N; Wu Q; Yuan Y; Yang Z; Zhou M; Zhu J; Tang Q
    Int J Mol Med; 2017 Jan; 39(1):199-207. PubMed ID: 27959392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ginsenoside Rd contributes the attenuation of cardiac hypertrophy in vivo and in vitro.
    Zhang N; An X; Lang P; Wang F; Xie Y
    Biomed Pharmacother; 2019 Jan; 109():1016-1023. PubMed ID: 30551351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperoside Protects Against Pressure Overload-Induced Cardiac Remodeling via the AKT Signaling Pathway.
    Wang X; Liu Y; Xiao L; Li L; Zhao X; Yang L; Chen N; Gao L; Zhang J
    Cell Physiol Biochem; 2018; 51(2):827-841. PubMed ID: 30466089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 17 Beta-estradiol differentially affects left ventricular and cardiomyocyte hypertrophy following myocardial infarction and pressure overload.
    Patten RD; Pourati I; Aronovitz MJ; Alsheikh-Ali A; Eder S; Force T; Mendelsohn ME; Karas RH
    J Card Fail; 2008 Apr; 14(3):245-53. PubMed ID: 18381189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Caffeic acid phenethyl ester attenuates pathological cardiac hypertrophy by regulation of MEK/ERK signaling pathway in vivo and vitro.
    Ren J; Zhang N; Liao H; Chen S; Xu L; Li J; Yang Z; Deng W; Tang Q
    Life Sci; 2017 Jul; 181():53-61. PubMed ID: 28449869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phillyrin attenuates norepinephrine-induced cardiac hypertrophy and inflammatory response by suppressing p38/ERK1/2 MAPK and AKT/NF-kappaB pathways.
    Tang K; Zhong B; Luo Q; Liu Q; Chen X; Cao D; Li X; Yang S
    Eur J Pharmacol; 2022 Jul; 927():175022. PubMed ID: 35569549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kaempferol Attenuates Cardiac Hypertrophy via Regulation of ASK1/MAPK Signaling Pathway and Oxidative Stress.
    Feng H; Cao J; Zhang G; Wang Y
    Planta Med; 2017 Jul; 83(10):837-845. PubMed ID: 28219095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of LRRC25 accelerates pathological cardiac hypertrophy through promoting fibrosis and inflammation regulated by TGF-β1.
    Zhang X; Zhang MC; Wang CT
    Biochem Biophys Res Commun; 2018 Nov; 506(1):137-144. PubMed ID: 30340835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclin-Dependent Kinase Inhibitor p21WAF1/CIP1 Facilitates the Development of Cardiac Hypertrophy.
    Tong YF; Wang Y; Ding YY; Li JM; Pan XC; Lu XL; Chen XH; Liu Y; Zhang HG
    Cell Physiol Biochem; 2017; 42(4):1645-1656. PubMed ID: 28746924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased KCNE2 Expression Participates in the Development of Cardiac Hypertrophy by Regulation of Calcineurin-NFAT (Nuclear Factor of Activated T Cells) and Mitogen-Activated Protein Kinase Pathways.
    Liu W; Deng J; Ding W; Wang G; Shen Y; Zheng J; Zhang X; Luo Y; Lv C; Wang Y; Chen L; Yan D; Boudreau RL; Song LS; Liu J
    Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Naringenin attenuates pressure overload-induced cardiac hypertrophy.
    Zhang N; Yang Z; Yuan Y; Li F; Liu Y; Ma Z; Liao H; Bian Z; Zhang Y; Zhou H; Deng W; Zhou M; Tang Q
    Exp Ther Med; 2015 Dec; 10(6):2206-2212. PubMed ID: 26668617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.